Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 160 participants.
Also called NCT01007279
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 160 participants
- Registry
-
NCT01007279
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT01007279. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2010-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)
- Acronym
- ROMA
- Condition
- Periprocedural Myocardial Necrosis
- Intervention (Drug)
- ROSUVASTATIN
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01007279- Content hash
51ba67ab995f20f3cc0a4bff815f1ed0498c025b727673c1454a9c8ad6913d26